Abstract C081: Discovery and characterization of AKT1-E17K mutant-selective inhibitors for the treatment of AKT1-E17K mutant cancersTine Wyseure, Matt Patricelli, Zoe Rush et al.|Molecular Cancer Therapeutics|2025Cited by 0